ArticleAnti-cancer drugs2018

Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species.

Xiangcheng Qing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.